Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 101195

In scope icon M 1 D
QID 101195 (Type "101195" in App Search)
A 31-year-old male with cirrhosis, dementia, and Parkinson-like symptoms is diagnosed with a hereditary metabolic disease resulting from the accumulation of a certain metal in various tissues. Impairment of which of the following elimination pathways is most likely responsible?

Secretion into bile

68%

192/283

Loop of Henle secretion into lumen of kidney

8%

23/283

Glomerular filtration

11%

32/283

Bleeding

3%

9/283

Duodenal secretion

6%

18/283

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient is suffering from Wilson disease, a disorder that results from copper deposition in various tissues.
The main route of copper elimination, and that impaired in Wilson disease, is via hepatocyte-mediated secretion of copper into the bile.

In Wilson disease, also known as hepatolenticular degeneration, a defect in the ATP7B gene product, P-type copper ATPase, leads to impaired copper trafficking and secretion into the bile. This results in copper accumulation within liver cells and the eventual release of free copper into circulation. Free copper generates free radicals that damage tissues.

Heidelbaugh and Bruderly discuss the diagnostic evaluation of patients with cirrhosis and chronic liver failure. If one suspects Wilson disease (usually in a patient younger than 40 years with family history of liver disease), serum ceruloplasmin and copper levels should be measured. However, the authors note that screening all patients with chronic hepatic injury for Wilson disease is not indicated.

Treatment for Wilson disease consists of a low-copper diet and lifelong copper chelating agents. Wiggelinkhuizen et al. conducted a systematic review of 1 randomized trial and 12 observational studies evaluating D-penicillamine, trientine, tetrathiomolybdate, or zinc monotherapy as initial treatment for Wilson disease. The authors concluded that insufficient evidence existed to determine relative treatment effects of the various drugs.

Illustration A depicts copper metabolism in patients with Wilson disease. Note that there is reduced excretion and, thus, retention of copper.
Illustration B shows an histology image of hepatocytes in Wilson's disease. The rhodadine stain highlights the copper deposition.

Incorrect Answers:
Answer 2: Copper is not secreted by the Loop of Henle.
Answer 3: Though copper is filtered by the kidneys, this is not the major route of copper elimination as less than 20% is eliminated this way.
Answer 4: Though bleeding may lead to copper loss, this is not the body's major pathway of copper elimination.
Answer 5: Copper is not secreted by the duodenum, instead, copper is absorbed in the duodenum.

ILLUSTRATIONS:
REFERENCES (2)
Authors
Rating
Please Rate Question Quality

4.5

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(4)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options